Based on the expression status of Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Progesterone Receptor (PR), breast cancer can be classified into four molecular subtypes: Luminal A, Luminal B, HER2-positive, and triple-negative breast cancer. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.